SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development,...
Hence then, the article about sk biopharmaceuticals launches joint venture with eurofarma for ai based epilepsy management platform was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform )
Also on site :
- How Nashville’s Music Row Went MAGA in 2025
- Crew Paints Russian Flag on Oil Tanker Pursued by the U.S. Coast Guard
- FBI Seizes $40 Million Worth of Motorbikes Tied to Top-10 Fugitive